Head of Department
Biology
Asinex Corporation
Russian Federation
Dr. Grinevich has more than 20 years of R&D experience in both biotech and pharmaceutical settings, undertaking a range of projects in the pre-clinical and clinical stages of drug discovery and development. He joined Asinex in 2014 with a special focus on pharmacological characterization of new chemical entities at the molecular and cellular level. Dr. Grinevich has held positions of increasing responsibility at Asinex and was appointed Head of Biology in early 2017.
Protein-Protein interactions WNT/ β-catenin Apoptosis Infectious diseases